(4-Bromophenyl)[2-fluoro-4-[[6-(methyl-2-propenylamino)hexyl]oxy]phenyl]methanone

CAS: 161582-11-2

Ref. 3D-FB100752

Informação sobre produto

• Nome: (4-Bromophenyl)[2-fluoro-4-[[6-(methyl-2-propenylamino)hexyl]oxy]phenyl]methanone
• Sinónimos: (4-Bromophenyl)-[2-fluoro-4-[6-[methyl(prop-2-enyl)amino]hexoxy]phenyl]methanone, (4-Bromophenyl)[2-Fluoro-4-({6-[Methyl(Prop-2-En-1-Yl)Amino]Hexyl}Oxy)Phenyl]Methanone, (4-Bromophenyl)[2-fluoro-4-[[6-(methyl-2-propen-1-ylamino)hexyl]oxy]phenyl]methanone, Methanone, (4-bromophenyl)[2-fluoro-4-[[6-(methyl-2-propen-1-ylamino)hexyl]oxy]phenyl]-, Methanone, (4-bromophenyl)[2-fluoro-4-[[6-(methyl-2-propenylamino)hexyl]oxy]phenyl]-, Ro 48-8071

Descrição

4-Bromophenyl[2-fluoro-4-[[6-(methyl-2-propenylamino)hexyl]oxy]phenyl]methanone (BPPM) is a small molecule that binds to ATP binding cassette transporter proteins. BPPM has been shown to inhibit prostate cancer cell growth and induce apoptosis in vitro. It also has an inhibitory effect on the angiogenic process, which may be due to its ability to inhibit cholesterol synthesis. The drug is currently undergoing preclinical studies as a potential anti-cancer compound with inhibitory properties against cancer cells.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 448.37 g/mol
• Fórmula: C₂₃H₂₇BrFNO₂
• Pureza: Min. 95%